About Careers Internship MedBlog Contact us

Risk of Colorectal Cancer High With Elevated Glucose Levels, Insulin

by Medindia Content Team on November 3, 2007 at 6:41 PM
Risk of Colorectal Cancer High With Elevated Glucose Levels, Insulin

Scientists have found that elevated levels of glucose and insulin raise the risk developing recurrent colorectal cancer. The researchers say that they have unearthed evidence that elevated glucose is firmly associated with recurrence of colon polyps, the precursor lesions to colon cancer.

"This is the first study to determine whether elevated glucose or insulin as measured when or shortly after a patient has had polyps removed during a baseline colonoscopy procedure increases their risk for subsequent recurrence of pre-cancerous growths in the colon," said Dr. Andrew Flood of the University of Minnesota, who is the lead author of the study published in Gastroenterology.


"The results of our study have important clinical implications with respect to maintenance of glycemic control in patients with a history of colorectal polyps," he added.

According to the researchers, study subjects with even modestly impaired fasting glucose—an early sign of insulin resistance, which itself is a precursor of diabetes—particularly had an increased risk of recurrence of the types of polyps that are most likely to progress to invasive cancer.

The study, a part of the Polyp Prevention Trial, also suggested that even a modest elevation of fasting glucose could affect a patient's risk of developing colorectal cancer. The researchers said that patients with highest levels of both insulin and glucose had an approximately 50 per cent increased risk of colorectal tumour recurrence.

They also found that among subjects with a family history of colorectal cancer, the risk of developing the disease due to elevated concentrations of insulin and glucose was even greater as compared to the overall study population.

Source: ANI
Font : A-A+



Recommended Readings

Latest Cancer News

Oral Lipid Nanoparticle Drug Averts Colitis-Associated Cancer Development
Lipid nanoparticles use M13, a potent anti-ulcerative colitis compound, in an oral formulation to combat colitis-linked cancer.
Breast Reconstruction and Shorter Radiation: The Winning Combo!
Shorter radiation course is just as good as the regular one for women choosing breast reconstruction after mastectomy, saving time and money.
Innovative Cancer Implant Technology Holds Promise to Cut Death Rates by Half
HAMMR's small size permits minimally invasive implantation, monitoring cancer status, and dynamically adjusting immunotherapy, akin to a glucose monitor.
Personalized Vaccine and T Cell Therapy for Ovarian Cancer Patients
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Kinase-Targeted Therapy Revolutionizes Colorectal Cancer Care
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Risk of Colorectal Cancer High With Elevated Glucose Levels, Insulin Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests